Alexandra Stolzing
Overview
Explore the profile of Alexandra Stolzing including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
2456
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Burton D, Stolzing A
Ageing Res Rev
. 2018 Feb;
43:17-25.
PMID: 29427795
In response to persistent DNA damage, induction into cell senescence promotes an immunogenic program which facilitates immune clearance of these damaged cells. Under physiological conditions, senescent cells can activate both...
22.
Fabian C, Naaldijk Y, Leovsky C, Johnson A, Rudolph L, Jaeger C, et al.
Stem Cell Res Ther
. 2017 Apr;
8(1):85.
PMID: 28420415
Background: Mesenchymal stem cells (MSCs) show therapeutic efficacy in many different age-related degenerative diseases, including Alzheimer's disease. Very little is currently known about whether or not aging impacts the transplantation...
23.
Naaldijk Y, Johnson A, Friedrich-Stockigt A, Stolzing A
BMC Biotechnol
. 2016 Dec;
16(1):85.
PMID: 27903244
Background: Preservation of human skin fibroblasts and keratinocytes is essential for the creation of skin tissue banks. For successful cryopreservation of cells, selection of an appropriate cryoprotectant agent (CPA) is...
24.
Hamidouche Z, Rother K, Przybilla J, Krinner A, Clay D, Hopp L, et al.
Stem Cells
. 2016 Oct;
35(3):694-704.
PMID: 27734598
The molecular mechanisms by which heterogeneity, a major characteristic of stem cells, is achieved are yet unclear. We here study the expression of the membrane stem cell antigen-1 (Sca-1) in...
25.
Johnson A, Naaldijk Y, Hohaus C, Meisel H, Krystel I, Stolzing A
Aging (Albany NY)
. 2016 Sep;
9(2):340-352.
PMID: 27638293
Adipose-derived mesenchymal stem cells (ADSCs) are multipotent stem cells that promote therapeutic effects and are frequently used in autologous applications. Little is known about how ADSCs respond to genotoxic stress...
26.
Matjusaitis M, Chin G, Sarnoski E, Stolzing A
Ageing Res Rev
. 2016 May;
29:1-12.
PMID: 27212009
Aging is the main risk factor for many degenerative diseases and declining health. Senescent cells are part of the underlying mechanism for time-dependent tissue dysfunction. These cells can negatively affect...
27.
Heathman T, Stolzing A, Fabian C, Rafiq Q, Coopman K, Nienow A, et al.
Cytotherapy
. 2016 Mar;
18(4):523-35.
PMID: 26971681
Background Aims: The selection of medium and associated reagents for human mesenchymal stromal cell (hMSC) culture forms an integral part of manufacturing process development and must be suitable for multiple...
28.
Laube M, Stolzing A, Thome U, Fabian C
Int J Biochem Cell Biol
. 2016 Mar;
74:18-32.
PMID: 26928452
Preterm infants frequently suffer from pulmonary complications resulting in significant morbidity and mortality. Physiological and structural lung immaturity impairs perinatal lung transition to air breathing resulting in respiratory distress. Mechanical...
29.
Leovsky C, Fabian C, Naaldijk Y, Jager C, Jang H, Bohme J, et al.
Cytotherapy
. 2015 Oct;
17(11):1617-26.
PMID: 26432561
Background Aims: The age of both the donor and the recipient has a potential influence on the efficacy of various cell therapies, but the underlying mechanisms are still being charted....
30.
Heathman T, Stolzing A, Fabian C, Rafiq Q, Coopman K, Nienow A, et al.
Cytotherapy
. 2015 Oct;
17(11):1524-35.
PMID: 26432558
Background Aims: The cost-effective production of human mesenchymal stromal cells (hMSCs) for off-the-shelf and patient specific therapies will require an increasing focus on improving product yield and driving manufacturing consistency....